Denosumab decreases risk of symptomatic skeletal events in postmenopausal women with breast cancer infocusrx today 2:56 5 years ago 103 Скачать Далее
Denosumab Reduces Recurrence Risk in Postmenopausal HR+ Breast Cancer Breastcancer.org 1:35 8 years ago 328 Скачать Далее
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients ecancer 5:20 9 years ago 276 Скачать Далее
Which drug is more effective for the treatment of breast cancer: denosumab or bisphosphonates? VJOncology 1:15 7 years ago 638 Скачать Далее
Denosumab improves disease-free survival for postmenopausal HR-positive breast cancer ecancer 4:43 8 years ago 1 321 Скачать Далее
Treating Bone Mets with Adam Brufsky, MD, PhD Living Beyond Breast Cancer 56:05 4 years ago 6 134 Скачать Далее
Managing Skeletal-Related Events in Breast Cancer, Part II OncLive 8:40 11 years ago 252 Скачать Далее
Bone metastases: Role of zoledronic acid, denosumab and other strategies HMP Education 17:23 7 years ago 25 301 Скачать Далее
Phase III trial of denosumab for breast cancer risk reduction in BRCA1 carriers VJOncology 1:21 3 years ago 148 Скачать Далее
Dr. Julie Gralow on Treating Breast Cancer Bone Metastases OncLive 2:11 12 years ago 9 896 Скачать Далее
Discussion in clinic about adjuvant bone therapy in breast cancer Cancer Academy 9:04 3 years ago 1 563 Скачать Далее
Denosumab benefits postmenopausal breast cancer patients. Studiengruppe ABCSG 4:43 8 years ago 123 Скачать Далее
